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Sex-Specific Genetic Architecture of Whole Blood Serotonin Levels
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Departments of 1Human Genetics and 2Psychiatry, The University of Chicago, Chicago
Recently, a quantitative-trait locus (QTL) for whole blood serotonin level was identified in a genomewide linkage
and association study in a founder population. Because serotonin level is a sexually dimorphic trait, in the present
study, we evaluated the sex-specific genetic architecture of whole blood serotonin level in the same population.
Here, we use an extended homozygosity-by-descent linkage method that is suitable for large complex pedigrees.
Although both males and females have high broad heritability ( ), females have a higher additive com-2H p 0.99
ponent ( in females; in males). Furthermore, the serotonin QTL on 17q that was identified2 2h p 0.63 h p 0.27
previously in this population, integrin b3 (ITGB3), and a novel locus on 2q influence serotonin levels only in males,
whereas linkage to a region on chromosome 6q is specific to females. Both sexes contribute to linkage signals on
12q and 16p. There were, overall, more associations meeting criteria for suggestive significance in males than in
females, including those of ITGB3 and the serotonin transporter gene (5HTT). This analysis is consistent with
heritable sexual dimorphism in whole blood serotonin levels resulting from the effects of a combination of sex-
specific and sex-independent loci.
Introduction
Genetically complex traits, which likely determine most
of the heritable variation in humans, pose challenges to
the gene-mapping community. In particular, gene-envi-
ronment and gene-gene interactions, genetic heteroge-
neity, and incomplete penetrance make thorough genetic
dissection of complex traits difficult, if not impossible.
Gene-environment interactions are most often ignored
by geneticists, simply because we know little about the
environmental factors that influence the expression of
most traits or about how to incorporate known envi-
ronmental factors into our genetic models. Sex could be
considered an environmental factor that can modify
both the penetrance and expressivity of a wide variety
of traits. Sex is easily determined and has measurable
effects on recognizable morphology, neurobiological cir-
cuits, susceptibility to autoimmune disease, and quan-
titative traits like hypertension, obesity, and lipid levels,
among others. In fact, sex-specific genetic influence has
been found even for traits with no prior evidence of
sexual dimorphism. For example, although phenotypic
differences between the sexes in fasting glucose level are
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not evident, men show higher heritability for this trait
than do women (Schousboe et al. 2003). Thus, it is pos-
sible that autosomal loci have sex-specific effects on a
wide range of human traits, as has been observed for
heritable quantitative traits in model organisms (Mackay
2001).
The serotonin system contributes to complex traits,
including cognition, affect, endocrine regulation, neu-
rotrophic effects, pain, appetite, emesis, sex, sleep, ag-
gression, perception, sensory-motor function, and vas-
cular and gastrointestinal regulation (Heninger 1997),
and the role of serotonin in some of these traits is sex
limited. For example, serotonin dysfunction has been
observed in women with premenstrual dysphoric dis-
order (Steiner et al. 1999), and serotonin is thought
to contribute to aggression in males by interacting with
testosterone (Clark and Henderson 2003). In sever-
al population studies, females had increased average
whole blood serotonin, as compared with males (Ash-
croft et al. 1964; Wirz-Justice et al. 1977; Gonzales
1980; Ortiz et al. 1988). Although the genetic basis
underlying variation in serotonin levels is not well un-
derstood, heritability estimates (narrow heritability [h2]
0.52; broad heritability [H2] 0.99) suggest that it is
strongly genetically regulated (Abney et al. 2001). There-
fore, an examination of gene-sex interactions with regard
to serotonin level could identify sex differences in the
genetic architecture of this trait and could further elu-
cidate its underlying etiology.
Recently, genomewide linkage and association map-
ping was performed for whole blood serotonin levels in
the Hutterites, a founder population of European de-
scent (Weiss et al. 2004). In that study, we identified a
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novel QTL, integrin b3 (ITGB3), on chromosome 17q.
One additional linkage result on chromosome 16p met
criteria for suggestive significance. The goal of the pre-
sent study was to examine whether there are different
male and female genetic contributions to interindividual
variation in serotonin levels and different contributions
to the evidence for linkage and association for this trait
in the Hutterites.
Material and Methods
Subjects
The Hutterites are a young founder population who
practice a communal agricultural lifestyle. Details of the
population, the sampling strategy, and the utility of this
population for mapping complex traits have been de-
scribed elsewhere (Abney et al. 2000; Ober et al. 2001;
Weiss et al. 2004). The 806 Hutterites in our studies are
related to each other through multiple lines of descent
in a known pedigree. The mean inbreeding coefficient
of the individuals in this sample is 0.034 (SD 0.015),
slightly greater than that of 1.5 cousins. A complete
genealogy of 806 individuals was constructed from a
112,000-member Hutterite pedigree. This yielded a
1,623-person pedigree that included all known ancestors
of the 806 individuals (Abney et al. 2000). Whole blood
serotonin was measured in 567 of these Hutterites (300
females; 267 males) after informed consent was ob-
tained, as described elsewhere (Ober et al. 2001; Weiss
et al. 2004). Whole blood serotonin measurements were
ln transformed to establish a normal distribution. Dis-
tributions of the male-only sample, the female-only sam-
ple, and the whole sample were normal by the Kol-
mogorov-Smirnov test ( ). The mean age of femalesP 1 .9
was 27.1 years (SD 15.0; range 5–89); the mean age of
males was 27.0 years (SD 15.1; range 6–79). This study
was approved by the institutional review boards of The
University of Chicago and the University of South Dakota.
Genotyping
A genome screen using 658 autosomal microsatellite
markers (Marshfield screening sets 9 and 51) was com-
pleted by the Mammalian Genotyping Service of the Na-
tional Heart, Lung, and Blood Institute, yielding an ∼5-
cM map (see Marshfield Web site). In addition, 226
microsatellite markers and 239 intragenic SNPs or in/
dels related to asthma and cardiovascular diseases (e.g.,
see Newman et al. [2004]) were genotyped in this sam-
ple. None of the markers were selected because they were
functional or positional “candidates” for serotonin lev-
els. Genotyping was performed blind to all phenotypic
information. Distances for framework markers were
based on the Marshfield map (see Marshfield Web site);
all other markers were placed by use of the physical map
(see UCSC Web site) and estimations of recombination
within the Hutterite pedigree as calcuated by CRI-MAP
(see CRI-MAP Web site). The final map had an average
intermarker distance of 3.2 cM.
Statistical Analysis
Estimation of heritability.—The methods used to esti-
mate narrow and broad heritability were described in
detail elsewhere (Abney et al. 2001) but will be briefly
reviewed here. We analyzed serotonin by use of a var-
iance-components maximum-likelihood method (Abney
et al. 2000). This method estimates additive, dominance,
and environmental variance by using information about
the kinship coefficient and the probability that a given
pair of individuals share two alleles identical by descent
(IBD) without either individual being autozygous. Ac-
curate estimation of the dominance variance, as opposed
to just a sibship correlation, is possible, because essen-
tially every pair of Hutterites has a nonzero probability
of sharing two alleles IBD. We considered models that
had—in addition to an environmental variance compo-
nent—only additive variance, only dominance variance,
and both additive and dominance variance components.
To assess the best-fitting model, we used the Bayesian
information criterion (Schwarz 1978) to compare the
models and used the likelihood-ratio x2 test to determine
which components (including sex) were significant.
Mapping.—Genome scans were performed using ho-
mozygosity-by-descent (HBD) linkage and allele-spe-
cific-HBD (ASHBD) association methods, and signif-
icance was assessed using a permutation-based method.
The linkage method tests for correlations between
regions inherited HBD and trait value, whereas ASHBD
tests for correlations between each allele at a marker
inherited HBD and trait value. For both methods, we
assess empirical locus-specific and genomewide signifi-
cance, using a Monte Carlo permutation test. This test
keeps the genotypes fixed while permuting trait values.
This has the advantage of assessing significance condi-
tional on characteristics of the genotype data (e.g., in-
formativeness, heterozygosity, and linkage disequilib-
rium) while preserving the covariance structure in the
phenotype data. The methods used in the present study
are identical to those described elsewhere (Abney et al.
2002), except that we have now extended the original
HBD computations to include genotype information
from related individuals (see appendix). Because of these
changes, the results of the genomewide screens vary
slightly from our previous report (Weiss et al. 2004).
All analyses were run first on the entire sample and
then separately by sex. In the sex-specific analyses, the
phenotype values for individuals of the opposite sex were
entered as missing data. Genomewide suggestive signif-
icance was met if the P value at a locus was less than
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the minimum P value expected under the null hypothesis,
which was estimated by finding the minimum locus-spe-
cific P value across the genome for each of 1,000 per-
mutations and averaging these values.
Locus-specific P values, on the basis of Gaussian the-
ory, were Bonferroni corrected, such that the number of
alleles at a marker locus equaled the number of tests for
ASHBD. The Bonferroni-corrected P values were very
close to the locus-specific permutation-based P values
(Abney et al. 2002). Although likelihood ratios were not
calculated, we can assign an equivalent 1-df LOD score
to each of our P values by using the formula LOD p
, where F1 is the inverse cumulative dis-10.217F (1  P)
tribution function of a x2 random variable with 1 df.
Results
Serotonin Levels
The mean whole blood serotonin level in the entire
sample was 191 ng/ml (SD 79). The mean for females
( ) was 206 ng/ml (SD 79) and the mean forN p 300
males ( ) was 174 ng/ml (SD 76). Sex was aN p 267
significant predictor in the best-fitting model for age-
adjusted, ln-transformed serotonin values (P p 2.4 #
).910
Heritability
In an earlier study of whole blood serotonin levels
in the Hutterites, the best-fitting heritability model in-
cluded both additive and dominance genetic effects (Ab-
ney et al. 2001). In that study, the narrow heritability
(h2) was estimated to be 0.52, and the broad heritability
(H2), to be 0.99, indicating that loci with both additive
and nonadditive effects influence serotonin levels (Abney
et al. 2001). In the sex-specific analyses, these estimates
were and in females and2 2 2h p 0.63 H p 0.99 h p
and in males. Thus, whereas the broad20.27 H p 0.99
heritabilities in males and females were similar to each
other (and to the combined sample), the additive genetic
component was greater in females (0.63  0.20), as
compared with that in males (0.27  0.21). Although,
in the combined sample, the model that included both
additive and dominance components was a significantly
better fit, in the sex-specific analyses, the models in-
cluding a dominance component were not significant-
ly better than purely additive models, in which 2h p
(likelihood-ratio x2, ) in females0.79  0.13 P p .11
and (likelihood-ratio x2, ) in2h p 0.59  0.15 P p .06
males. Therefore, we used both models (one with ad-
ditive and dominance components together and another
with just an additive component) for our mapping stud-
ies in males and females. However, because the results
were very similar (data not shown), we present here only
results for analyses using the model that includes both
additive and dominance components.
Linkage Results
In our previous genomewide linkage analysis of the
whole sample, one region on chromosome 16p at 35 cM
met the criteria for suggestive significance (Weiss et al.
2004). By use of the modified method for estimating
HBD, in the present study, the region on 16p at 35 cM
remained the most significant, but linkage signals at two
additional locations also met the criteria for suggestive
significance ( ): one on 16p at 46 cM and oneP ! .0020
on 12q at 150 cM (fig. 1).
In the male-only analysis, regions on 2q (260 cM),
16p (56 cM), 17p (36 cM), and 17q (66 cM) reached
criteria for suggestive significance ( ) (fig. 1).P ! .0020
The region on 17q at 66 cM, with the most significant
linkage in males, contains ITGB3, the previously re-
ported QTL in this population.
In contrast, a region on 6q at 183 cM had the strong-
est linkage in the female-only analysis, meeting the cri-
teria for suggestive significance ( ) (fig. 1).P ! .0022
Whereas there was a small signal on 12q at 150 cM
( ; ) and on 16p at 34 cM and 46LOD p 1.0 P p .03
cM ( and 0.9; and .05, respectively),LOD p 0.7 P p .06
the regions on 2q, 17p, 17q, and 16p at 56 cM that
were suggestive for linkage in males showed no evidence
for linkage in females ( ). Similarly, the region onP 1 .1
6q that was most significant in females had no evidence
for linkage in males ( ).P 1 .1
Association Results
The results of the genomewide association analysis of
the entire sample were similar to what was reported
elsewhere (Weiss et al. 2004): only one association met
the criteria for suggestive significance ( ), in aP ! .00045
region corresponding to the linkage peak on chromo-
some 17 at 66 cM (ITGB3 L33P [dbSNP accession num-
ber rs5918]) (table 1). However, many more associations
met this criteria in the sex-specific analyses. Although,
in females, only one association (on chromosome 10)
met the criteria for suggestive significance ( ),P ! .00065
suggestive associations were observed at seven loci in
males ( ), including ITGB3 and 5HTT onP ! .00058
chromosome 17 (table 1). The 5HTT locus (also known
as “SLC6A4” or “SERT”) encodes the serotonin trans-
porter, at which variation has been associated with
whole blood serotonin level and with autism (Cook et
al. 1997; Klauck et al. 1997; Hanna et al. 1998; Tordj-
man et al. 2001; Yirmiya et al. 2001; Kim et al. 2002;
Conroy et al. 2004; McCauley et al. 2004). Furthermore,
evidence for linkage in families with autism to the region
on 17q that includes 5HTT and marker D17S1294 has
been reported (International Molecular Genetic Study of
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Table 1
Results of ASHBD Association Test with Serotonin Level
CHROMOSOME
AND LOCUS
DISTANCE
FROM P-TER
(cM)
ASSOCIATED
ALLELE FREQUENCY
P VALUEa FOR
All Samples Males Females
1:
D1S1589 192 205 .48 .0232 .0006 1.1
2:
D2S125 261 94 .20 .0028 .0003 1.1
10:
D10S1677 100 174 .32 .0504 1.1 .0005
17:
ATA58E08 47 111 .23 .0289 .0004 1.1
D17S1294 51 260 .22 .0106 .0002 1.1
5HTT_SNP09b 51 A .57 .0191 .0003 1.1
D17S1299 62 196 .55 .0005 .0001 1.1
ITGB3_33 66 L .80 .0002 .0003 .0751
NOTE.—All ASHBD results with P values reaching the threshold for suggestive significance (see
“Material and Methods” section) in one of the three samples are shown. All loci included here showed
association with decreased serotonin levels.
a P values are Bonferroni corrected (see “Material and Methods” section for details). Results in
bold italics met criteria for suggestive significance.
b dbSNP accession number rs2066713.
Figure 1 HBD linkage results with serotonin level. Locus-specific P values are shown on the left axis, with LOD equivalents on the right
axis (see “Material and Methods” section). The gray line denotes the threshold for suggestive significance. The thick black line shows results
for the full sample, the blue line shows results for males, and the pink line shows results for females.
Autism Consortium 2001; Yonan et al. 2003). It is per-
haps relevant, in light of our results, that autism is sig-
nificantly more prevalent in males (Fombonne 2003).
Covariate Analysis by Locus-Specific HBD
Elsewhere, we showed that HBD for the Leu33 allele
at the ITGB3 locus accounted for the linkage signal on
chromosome 17q in the combined sample (Weiss et al.
2004). Here, we repeated the linkage analysis including
the probability of HBD for the Leu33 allele as a covar-
iate in males and females separately.
As in our previous study, evidence for linkage on chro-
mosome 17 was nearly eliminated in the covariate anal-
ysis of the combined sample ( ). Thus, HBD forP p .79
the Leu33 allele—or for other variants that are in nearly
complete linkage disequilibrium with it—explained al-
most all the evidence for linkage on 17q. In the male-
only covariate analysis, the linkage peak in the ITGB3
region on 17q was also nearly completely eliminated
( ), confirming that it is a likely QTL for wholeP p .28
blood serotonin level in males. Notably, the peak on 17p,
which is 30 cM from ITGB3, was relatively unchanged
in the covariate analysis, indicating that these regions
are independent.
Discussion
Serotonin levels have long been reported to be sexually
dimorphic (Ashcroft et al. 1964; Wirz-Justice et al. 1977;
Gonzales 1980; Ortiz et al. 1988). Further, the serotonin
system has been implicated in differing male and female
susceptibility to phenotypes influenced by the peripheral
and central serotonergic systems, such as the increased
prevalence among females of mortality after ischemic
coronary events (Loop et al. 1983; Lerner and Kannel
1986; Weaver et al. 1996; Vaccarino et al. 1999) and of
major depression (Weissman and Olfson 1995; Gater et
al. 1998). In addition, selective serotonin-reuptake in-
hibitors (SSRIs) are more effective in treating depression
in women (Kornstein et al. 2000), suggesting sex dif-
ferences in metabolism and action of SSRIs.
In the present study, we not only show that whole
blood serotonin levels differ between male and female
Hutterites, but we also report, for the first time, that
the underlying genetic architecture differs between the
sexes. Although broad heritability was high in both
sexes ( ), female heritability had a larger ad-2H p 0.99
ditive component ( in females; in2 2h p 0.63 h p 0.27
males). Sex-specific heritabilities in humans have been
reported elsewhere for behavioral traits like aggression
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(van Beijsterveldt et al. 2003) and for quantitative traits
like fasting insulin level (Schousboe et al. 2003). In
model organisms, sex-specific differences in heritability
are common, such as for lifespan in Drosophila (Leips
and Mackay 2000) and for morphological traits in birds
(Jensen et al. 2003). Our mapping studies of serotonin
levels in the combined Hutterite sample, in males, and
in females revealed that different loci influence serotonin
levels in males and females. QTLs on chromosomes 17q
(ITGB3) and 2q are specific to males, whereas a locus
on chromosome 6q is specific to females (fig. 1). When
ITGB3 L33 was included as a covariate, the signal on
17q in males was eliminated, indicating that this is a
likely QTL. In humans, although many candidate genes
are tested for sex-specific effects, only a few other traits
have been found to have sex-specific susceptibility loci
in genomewide screens. Psychiatric traits—such as neu-
roticism (Fullerton et al. 2003) and mood disorders (Zu-
benko et al. 2003)—as well as immune-mediated dis-
orders—such as inflammatory bowel disease (Fisher et
al. 2002) and osteoarthritis (Loughlin et al. 2000)—
have shown sex-specific linkages.
Sex differences could result from parent-of-origin ef-
fects, linkage to or interaction with sex chromosomes,
or differences arising from sex-specific hormonal envi-
ronments. Our results did not separate individual ge-
notypes on the basis of parent of origin, so imprinting,
maternal effects, or mitochondrial inheritance would
not explain the differences in male and female linkage
signals observed in our study. Although we did not test
for linkage or association on the sex chromosomes, X-
or Y-linked loci that interact with autosomal loci could
theoretically explain our results. It should be noted that
the serotonin-metabolizing monoamine oxidases (MAO-
A and MAO-B) are encoded by genes on the X chro-
mosome and are good functional candidates to influence
serotonin level. However, a model of interaction with
sex-linked loci that would explain a female-specific lo-
cus on 6q and male-specific loci on 2q and 17q would
require multiple sex-linked genes. Therefore, a more bi-
ologically plausible mechanism may be that hormonal
interaction at the transcriptional or posttranslational
level underlies the sex-specific linkages and associations
observed in the study. In support of the latter mecha-
nism, ITGB3 mRNA levels were suppressed by estrogen
both in intercaruncular bovine stromal cells (Kimmins
et al. 2003) and in human osteoclasts (Saintier et al.
2004). Similarly, 5HTT mRNA expression in seroto-
nergic neurons was reduced by estrogen in Rhesus ma-
caques (Pecins-Thompson et al. 1998). If the trans effect
of estrogen on these loci in females is epistatic to effects
of interindividual cis variation, linkage and association
may be more difficult to detect in females, in whom
higher circulating levels of estrogen could mask the ef-
fects of genetic variation at these loci. Consistent with
this hypothesis, the linkage and association in the
regions containing ITGB3 and 5HTT on chromosome
17 in the Hutterites was present only in males. Re-
gardless of the mechanism for the sex-specific linkage
and association observed in our study, these data clearly
show that the loci influencing whole blood serotonin
levels differ between males and females.
Lastly, if the sex-specific genetic effects observed in
the present study are a more general phenomenon, then
these results would have broad implications for map-
ping complex trait genes. Failure to model for sex-spe-
cific architecture may significantly hamper the ability
to detect signals of susceptibility loci in genomewide
screens. In our study, only the two regions (16p and
12q) that show some evidence for linkage in both sexes
met criteria for suggestive significance in the combined
sample: the relatively larger effects of 17q and 2q in
males and 6q in females did not meet these criteria.
Thus, although combining data to increase sample size
or performing meta-analysis on different samples are
tempting approaches to increase power, caution should
be taken, since our results suggest that appropriately
choosing and subdividing populations or groups of pa-
tients may be critical for detection of linkage in complex
traits.
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Appendix
Here, we briefly describe the extensions made to the
original HBD computation, to include genotype infor-
mation from related individuals. The earlier version of
the HBD-linkage-mapping method computed the prob-
ability of an individual being HBD at a locus, conditional
on only the genotypes of that individual (Abney et al.
2002). Ignoring the genotypes of other individuals al-
lowed rapid estimation of HBD and proved to be a good
approximation, with sufficiently dense and informative
markers. However, in areas of the chromosome in which
information content is low, inclusion of genotype data
from other individuals improves the accuracy of the es-
timation. The computation of the probability of being
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HBD at a locus is based on a hidden Markov model
(HMM). The HMM relies on three basic quantities: the
inbreeding coefficient, the transition probabilities be-
tween HBD and non-HBD states, and the single-locus
probabilities of observing the marker-genotype data,
given the HBD state. Computation of the last of these
quantities was previously done solely on the basis of the
frequency of the observed marker alleles but is now done
conditional on all known ancestral genotypes at that
marker, for the individual in question. More precisely,
we compute the probability of HBD (or non-HBD),
given the genotype of the individual at the marker and
given the genotypes of all the individual’s ancestors at
that marker. The algorithm for accomplishing this uses
the same basic recursion strategy proposed by Davis et
al. (1996), with two important differences. The first dif-
ference is in the estimation of parent-offspring trans-
mission when parental genotype data is missing. For
instance, consider the case of a child having genotype
(1,2) at a marker, with the father’s genotype (1,2) and
the mother’s genotype unknown (0,0). Rather than as-
signing the probability of one-half to the child’s 1 allele
being inherited from the father and one-half to it being
inherited from the mother, we recursively look up the
maternal lineage and check genotypes. So, if the mater-
nal grandparents had genotypes (2,3) and (2,3), for ex-
ample, then we would assign a probability equal to zero
to the child’s 1 allele being inherited from the mother
and a probability equal to one to it being inherited from
the father. If the mother is a founder, then we assign the
probability that each of the mother’s alleles are of type
1 equal to the frequency of the allele. The transmission
probability, then, becomes weighted by the allele fre-
quency. If allele 1 were very rare, for instance, then the
probability that it was inherited from the father is in-
creased, whereas the probability that it was inherited
from the mother is decreased.
The other significant change in the algorithm is the
assumption of unrelated founders. Normally, in consid-
ering the IBD status of two alleles, the recursive strategy
will trace the possible paths of the alleles up the pedigree
until either the paths join—in which case the alleles are
IBD—or the paths end in different founders—in which
case the alleles are not IBD. In a very deep pedigree,
such as the Hutterites, in which there are many gener-
ations with untyped individuals, this approach gives
poor results. Instead, we apply the recursion only up to
the oldest typed individuals, a group we refer to as
“quasi-founders.” In this case, in which possible allele
paths end in separate quasi-founders, instead of assign-
ing a zero probability of the alleles being IBD, we com-
pute the probability of the alleles being IBD given the
genotypes of the two quasi-founders and their previously
computed identity coefficients (Abney et al. 2002). The
net result is that we are able to rapidly compute mul-
tilocus HBD probabilities across the genome conditional
on the individual’s genotypes and all the individual’s
ancestors’ genotypes in the entire intact Hutterite ped-
igree, for each of our study individuals.
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